Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 6, 2013

Elite, GSK, Novartis, Pacira, Rhizen, Shire, Theravance

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Rhizen begins FIH trial for blood diseases . . . read more Phase II Elite begins bioequivalence study of abuse-deterrent painkiller . . . read more TGT Starts CLL, MCL Trial . . . read more Phase III GSK, Theravance post good asthma results . . . read more Novartis myleoma treatment extends PFS . . . read more Shire eye drug misses clinical endpoint . . . read more Filings Pacira files PAS for Exparel . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters